Head and neck neoplasm
Therapeutic area
Oncology
Rare disease
No
- Definition
- A benign or malignant neoplasm that affects the anatomic structures of the head and neck region. Representative examples of benign neoplasms include salivary gland pleomorphic adenoma and nasal cavity papilloma. Representative examples of malignant neoplasms include oral cavity squamous cell carcinoma, laryngeal squamous cell carcinoma, and salivary gland carcinoma.
- Genetic basis
- No
- Non-human condition
- No
- Rare disease
- No
- Listing at source
- Listed
- Condition name
- Head and neck neoplasm
- Therapeutic area
- Oncology
- head and neck neoplasm
- craniocervical region neoplasm
- craniocervical region neoplasm (disease)
- craniocervical region tumor
- craniocervical region tumour
- head and neck neoplasm
- head and neck neoplasm (excluding central nervous system)
- head and neck tumor
- head and neck tumour
- neoplasm of craniocervical region
- neoplasm of head and neck
- neoplasm of the head and neck
- tumor of craniocervical region
- tumor of head and neck
- tumor of the head and neck
- tumour of craniocervical region
- tumour of head and neck
- tumour of the head and neck
- All therapeutic areas
- Oncology
- Severity
- Moderate
- MONDO ID
- MONDO:0005586
- Parent condition
- MONDO:0005070
Related records
Broader conditions (6)
- Cancer or benign tumor
- Disease
- Disease by etiologic mechanism
- Human disease
- Neoplasm
- Neoplastic disease or syndrome
Narrower conditions (519)
- Abducens nerve neoplasm
- ACTH-producing pituitary gland adenoma
- ACTH-producing pituitary gland carcinoma
- ACTH-producing pituitary gland neoplasm
- Adamantinous craniopharyngioma
- Adenoid ameloblastoma
- Adenoid cystic carcinoma of oropharynx
- Ameloblastic carcinoma
- Ameloblastoma
- Angiosarcoma of the scalp
- Aniridia 2
- Aniridia 3
- Anterior foramen magnum meningioma
- Aryepiglottic fold cancer
- Benign carotid body paraganglioma
- Benign conjunctival neoplasm
- Benign epithelial tumor of salivary glands
- Benign eyelid neoplasm
- Benign neoplasm of buccal mucosa
- Benign neoplasm of choroid
Trials (2,662)
- "Effect of Low Level Laser Therapy on Neuropathic Pain After Neck Dissection Surgery''
- "QUAD SHOT" Radiotherapy With Pembrolizumab in Patients With Recurrent Head & Neck Cancer
- [177Lu]Lu-AKIR001 First-in-human Study
- [18F]HX4 PET/CT Imaging for Detection of Hypoxia
- [212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
- [Ga-68]MTP220 PET for Biodistribution and Efficacy in Pancreatic Cancer and Head and Neck Cancers
- 131Iodine-Tenatumomab Treatment in Tenascin-C Positive Cancer Patients
- 177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
- 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors
- 2 Phase Use Of Educational Materials In Head And Neck Cancer Center
- 2B or Not 2B? Shoulder Function After Level 2B Neck Dissection: A Randomized Controlled Study
- 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or Hypopharynx
- 3D Modeling of the Cervico-facial Region and Cranial Nerve Tractography: IMAG 2 ORL Project
- 3D Printed Oral Stents for Patients With Head and Neck Cancer Receiving Radiation Therapy
- 3D Specimen Maps for RT Planning
- 3D Ultrasound, Specimen Examination by Surgeon, and MRI in Surgical Margin Assessment
- 3D-PCT Combined With CT-guided Radioactive I-125 Seed Implantation in the Treatment of Head and Neck Tumors
- 4-HPR and FTI in Head and Neck Squamous Cell Carcinoma (HNSCC)
- 99mTc Labeled FAP Targeted Molecular Probe in Early Diagnosis of Tumors
- A 3D Analysis of Mandibular Plating Strategies in Oromandibular Reconstruction.
Approved drugs (4)
Drugs in development (13)
- Atezolizumab Phase 2
- Belrestotug Phase 2
- Carboplatin Phase 3
- Cisplatin Phase 3
- Dostarlimab Phase 3
- Feladilimab Phase 2
- Fluorouracil Phase 3
- Foretinib Phase 2
- Lapatinib Phase 3
- Nelistotug Phase 2
- Peltopepimut-S Phase 1
- Pembrolizumab Phase 3
- Pexipepimut-S Phase 1
Other linked drugs (1)
- Erlotinib hydrochloride